IP Library Granted Patent US 7,129,077
Granted Patent B2
US 7,129,077 · App. 10/483,192 · Granted Oct 31, 2006

Regulation of human aminopeptidase N

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,129,077
App. No.
10/483,192
Granted
Oct 31, 2006
Kind
B2
Abstract

Reagents that regulate human aminopeptidase N and reagents which bind to human aminopeptidase N gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, a CNS disorder or COPD.

Claims (21)

1. An isolated and purified protein comprising a first polypeptide segment comprising the amino acid sequence shown in SEQ ID NO:2.

2. The protein of claim 1 further comprising a second polypeptide segment comprising an amino acid sequence which is not the amino acid sequence of SEQ ID NO:2, wherein the second polypeptide segment is joined to the first polypeptide segment by means of a peptide bond.

3. An isolated and purified polynucleotide which encodes the amino acid sequence shown in SEQ ID NO:2.

4. The polynucleotide of claim 3 which comprises the nucleotide sequence shown in SEQ ID NO:1.

5. The polynucleotide of claim 3 which is a cDNA.

6. An expression construct comprising:

(a) a polynucleotide encoding the amino acid sequence shown in SEQ ID NO:2 and

(b) a promoter which is located upstream from the coding sequence and which controls expression of the coding sequence.

7. The expression construct of claim 6 wherein the polynucleotide comprises the nucleotide sequence of SEQ ID NO:1.

8. A host cell comprising an expression construct, wherein the expression construct comprises (a) a polynucleotide encoding a protein comprising the amino acid sequence shown in SEQ ID NO:2 and (b) a promoter which is located upstream from the coding sequence and which controls expression of the coding sequence.

9. The host cell of claim 8 which is prokaryotic.

10. The host cell of claim 8 which is eukaryotic.

11. A method of producing a protein, comprising the steps of:

culturing a host cell in a culture medium, wherein the host cell comprises an expression construct comprising (a) a polynucleotide encoding a protein comprising the amino acid sequence shown in SEQ ID NO:2 and (b) a promoter which is located upstream from the coding sequence and which controls expression of the coding sequence, wherein the step of culturing is carried out under conditions whereby the protein is expressed; and

recovering the protein.

12. A method of identifying a compound which binds to a protein comprising the amino acid sequence shown in SEQ ID NO:2 comprising:

contacting the protein with a test compound;

assaying for binding between the protein and the test compound; and

identifying a test compound that binds to the protein by detecting the binding of the compound to the protein.

13. The method of claim 12 wherein either the test compound or the protein comprises a detectable label.

14. The method of claim 12 wherein either the test compound or the protein is bound to a solid support.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2013
From: BAYER PHARMA AG
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029839/0959 →
CHANGE OF NAME Recorded Oct 18, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AG
Reel/Frame 029150/0303 →
MERGER Recorded Feb 19, 2009
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AG
Reel/Frame 022277/0324 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2004
From: SMOLYAR, ALEX
To: BAYER HEALTHCARE AG
Reel/Frame 015599/0994 →